SymbolPODD
NameINSULET CORP
SectorHEALTH CARE
RegionNorth America
IndustrySurgical & Medical Instruments & Apparatus
Address100 NAGOG PARK, ACTON, MA 01720
Telephone978-600-7000
Fax
Email
Websitehttps://www.insulet.com
IncorporationUNDEFINED
Incorporated On
Employees
Fiscal Year
Public Since
ExchangesNASDAQ
Auditor
Audit StatusNOT PROVIDED
Reporting Status
CIK0001145197
Description

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 150,000 insulin-dependent diabetics are using it worldwide.

Additional info from NASDAQ:
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 150,000 insulin-dependent diabetics are using it worldwide.

2026-07-07 19:33

PODD Fraud Alert: Insulet Corporation Sued for Securities Fraud after Safety Issues Lead to a 6% Stock Drop – Investors Notified to Contact BFA Law

Read more
2026-07-07 17:42

New Form 4/A - INSULET CORP <b>Filed:</b> 2026-07-07 <b>AccNo:</b> 0001145197-26-000159 <b>Size:</b> 5 KB

Read more
2026-07-07 17:16

Deadline Approaching: Insulet Corporation (PODD) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith

Read more
2026-07-06 23:00

INVESTOR ALERT: Securities Class Action Filed Against Insulet Corporation – Investors Encouraged to Contact Kirby McInerney LLP

Read more
2026-07-06 16:06

Law Offices of Frank R. Cruz Encourages Insulet Corporation (PODD) Shareholders To Inquire About Securities Fraud Class Action

Read more
2026-07-06 16:00

Bronstein, Gewirtz & Grossman LLC Urges Insulet Corporation Investors to Act: Class Action Filed Alleging Investor Harm

Read more
2026-07-06 11:00

Insulet - Insulet Accelerates Global Growth with Launch ofOmnipod® 5 and Omnipod Discover™ in Spain, Expanding Access to Tubeless Diabetes Technology

Read more
2026-07-06 11:00

Insulet Accelerates Global Growth with Launch of Omnipod® 5 and Omnipod Discover™ in Spain, Expanding Access to Tubeless Diabetes Technology

Read more
2026-07-05 18:45

Rosen Law Firm Urges Insulet Corporation (NASDAQ: PODD) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Read more
2026-07-03 23:12

PODD Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Insulet Corporation

Read more